Grifols to acquire remaining stake in Alkahest for $146m
Spanish pharmaceutical company Grifols has agreed to acquire the remaining stake in clinical-stage biopharmaceutical company Alkahest, for a total of $146m, on a debt-free basis. Alkahest a was